The funding committees for the NIHR Invention for Innovation (i4i) Programme are multidisciplinary, comprising academic, clinical and commercial experts, as well as patient and public members. i4i has four committees: two for Product Development Awards (committee A and committee B), one for Challenge Awards, and one for Connect.
Committee members - Product Development Awards Selection Committee A
| Name | Position | Organisation | Expertise |
|---|---|---|---|
| Ms Emma Palmer Foster (Chair) | Healthcare Consultant | EJ Palmer Consulting | Ms Foster has over 20 years experience in the European Healthcare sector gained through roles investment banking, investor relations, technology transfer and journalism. Emma now advises pharmaceutical and biotech clients on their corporate and financial strategies, investor relations and financial communications |
| Professor Paul Sibbons (Deputy Chair) | Independent pre-clinical Consultant | Independent Consultant | Professor Sibbons has extensive experience in pre-clinical surgery, pathology, evaluation and interpretation. |
| Mr Ravi Chana | Head of Business Development |
Roche Diagnostics Limited | Mr Chana has a broad range of expertise in Business Development, Market Access, Health Economics, MedTech Commercialisation and Value Based Healthcare |
| Ms Mary Anne Cordeiro | Consultant to life science businesses | Science to Business Ltd | Ms Cordeiro is an experienced advisor and merchant banker to innovative companies in the healthcare sector, specifically in medical technology businesses. She has been working on the commercialisation and funding of innovative products and services since 1998 after a 15-year career as an investment banker |
| Ms Alice Evans | Co-Head, Governance and Sustainable Investment | BMO Global Asset Management (EMEA) | Ms Evans has extensive fund management experience running global equity funds with a focus on environmental, social and governance (ESG) issues, and specialises in the healthcare sector |
| Professor Gail Hayward | Associate Professor |
University of Oxford | Professor Hayward is experienced in diagnostics and infectious diseases research in primary care |
| Professor David Jayne | Professor (Clinical) | University of Leeds | Professor Jayne's expertise range from General surgery with coloproctology sub specialisation; Robotic & minimally invasive surgery; Gastrointestinal oncology; Global Surgery |
| Mr Derek Jerome | PPI representative | PPI representative | PPI representative |
| Dr Thomas Keeble | Cardiologist and Honorary Senior Clinical Lecturer | The Essex Cardiothoracic Centre and Anglia Ruskin University | Dr Keeble is an experienced cardiologist and senior clinical lecturer who primarily focuses on interventional cardiology and general cardiovascular research |
| Dr Zahid Latif | IVP Global Innovation | Shionogi Europe | Dr Latif is a qualified pharmacist with specialities in pharmaceutical drug discovery, natural product chemistry, pharmacy, regenerative medicine, cell based therapies and digital health |
| Professor James Moore | The Bagrit and Royal Academy of Engineering Chair in Medical Device Design | Imperial College London | Professor Moore's interests include Cardiovascular Biomechanics, Implantable Devices, and the Lymphatic System. Received multiple patents for medical devices and co-founded two startups |
| Dr Nick de Pennington | CEO | Ufonia Limited | Dr Pennington is the CEO and Founder of a health AI company; Innovation Lead at Oxford University Hospitals; former Clinical Lead of an NHS regional digital interoperability programme, and has a background as a neurosurgeon with over 15 years of frontline clinical experience |
| Dr Krishan Ramdoo | CEO Tympa Health and NHS Clinical Entrepreneur Fellow. | Northwick Park Institute for Medical Research | Dr Krishan has clinical, academic and commercial expertise. He has expertise in developing a product starting from a lab bench to commercial product. His academic project was funded and commerciased by initiating a company (TympaHealth). Dr. Krishan developed All-in-One Hearing Assessment System which is a class 1 and CE marked medical software. Moreover, it was approved by the FDA. |
| Dr Matthew Reeves | Senior Lecturer | University College London | Dr Reeves has a specialty in infectious diseases focusing primarily on human cytomegalovirus latency and reactivation, and viral pathogenesis in human transplantation |
| Dr Julie Simmonds | Managing Director, Equity Research | Panmure Gordon | Dr Simmonds has expertise in investment and financial analysis across the healthcare sector, including medical devices, digital health and biotechnology in small/medium UK companies and large European stocks. |
| Dr Andrew Sims | Head of Department, Northern Medical Physics and Clinical Engineering | The Newcastle upon Tyne Hospitals NHS Foundation Trust; Freeman Hospital, Newcastle upon Tyne | Dr Sims is a medical physicist specialising in health technology assessment, translational R&D and outcomes research with real-world healthcare data, mainly in med-tech and diagnostics |
| Dr Peter Watkinson | Associate Professor of Intensive Care Medicine | John Radcliffe Hospital | Dr Watkinson is a Consultant in intensive care and acute medicine. He has designed and run a number of studies in the field of wearable devices for monitoring patient deterioration in the hospital setting |
| Mr Tim Wright | Chief Executive Officer | Aqdot | Mr Wright is an experienced CEO with a background in the healthcare sector and pharmaceuticals. He has successfully developed, licensed and grown brands and businesses at all stages of their lifecycle |